Cristina Cigana

Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Differential Evolution of Achromobacter spp. Isolates in Upper and Lower Airways of People with Cystic Fibrosis.

Differential Evolution of Achromobacter spp. Isolates in Upper and Lower Airways of People with Cystic Fibrosis.

Journal: Pathogens (Basel, Switzerland)

Published: March 31, 2026

Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis.

Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis.

Journal: Pathogens (Basel, Switzerland)

Published: September 26, 2025

Anti-inflammatory therapies from bedside to bench: Frameworks to support preclinical development.

Anti-inflammatory therapies from bedside to bench: Frameworks to support preclinical development.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 29, 2025

Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus.

Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus.

Journal: American journal of respiratory cell and molecular biology

Published: September 23, 2024

Improving the Predictive Value of Preclinical Mouse Models of Pseudomonas aeruginosa Respiratory Infection to Evaluate Antibiotic Efficacy.

Improving the Predictive Value of Preclinical Mouse Models of Pseudomonas aeruginosa Respiratory Infection to Evaluate Antibiotic Efficacy.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 11, 2023

Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis.

Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis.

Journal: Microbiology spectrum

Published: January 10, 2023

Pamoic acid is an inhibitor of HMGB1·CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia.

Pamoic acid is an inhibitor of HMGB1·CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia.

Journal: Molecular medicine (Cambridge, Mass.)

Published: April 08, 2022

R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.

R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.

Journal: The European respiratory journal

Published: May 05, 2021

NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target.

NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target.

Journal: mBio

Published: April 21, 2021

Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model.

Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model.

Journal: Frontiers in microbiology

Published: October 23, 2020

The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.

The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.

Journal: mSphere

Published: October 15, 2020

Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation.

Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation.

Journal: ERJ open research

Published: September 10, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026